Follow
Oleg Sofrygin
Oleg Sofrygin
Division of Research, Kaiser Permanente Northern California
Verified email at kp.org
Title
Cited by
Cited by
Year
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion‐dependent thalassemia: a literature review
TE Delea, J Edelsberg, O Sofrygin, SK Thomas, JF Baladi, PD Phatak, ...
Transfusion 47 (10), 1919-1929, 2007
2312007
Causal inference for social network data
EL Ogburn, O Sofrygin, I Diaz, MJ Van der Laan
Journal of the American Statistical Association, 1-15, 2022
1332022
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system …
TE Delea, O Sofrygin, SK Thomas, JF Baladi, PD Phatak, TD Coates
Pharmacoeconomics 25, 329-342, 2007
1132007
Semi-parametric estimation and inference for the mean outcome of the single time-point intervention in a causally connected population
O Sofrygin, MJ van der Laan
Journal of causal inference 5 (1), 20160003, 2017
672017
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-α antagonists
M Vera-Llonch, E Massarotti, F Wolfe, N Shadick, R Westhovens, ...
The Journal of Rheumatology 35 (9), 1745-1753, 2008
562008
Child wasting and concurrent stunting in low-and middle-income countries
A Mertens, J Benjamin-Chung, JM Colford Jr, AE Hubbard, ...
Nature 621 (7979), 558-567, 2023
502023
Cost–effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate
M Vera-Llonch, E Massarotti, F Wolfe, N Shadick, R Westhovens, ...
Rheumatology 47 (4), 535-541, 2008
482008
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
D Weycker, O Sofrygin, K Seefeld, RG Deeter, J Legg, J Edelsberg
BMC Health Services Research 13, 1-10, 2013
472013
Early-childhood linear growth faltering in low-and middle-income countries
J Benjamin-Chung, A Mertens, JM Colford Jr, AE Hubbard, ...
Nature 621 (7979), 550-557, 2023
45*2023
Robust and flexible estimation of stochastic mediation effects: a proposed method and example in a randomized trial setting
KE Rudolph, O Sofrygin, W Zheng, MJ Van Der Laan
Epidemiologic methods 7 (1), 20170007, 2018
432018
Sequential double robustness in right-censored longitudinal models
AR Luedtke, O Sofrygin, MJ van der Laan, M Carone
arXiv preprint arXiv:1705.02459, 2017
432017
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective
TE Delea, K El-Ouagari, J Karnon, O Sofrygin
Breast cancer research and treatment 108, 375-387, 2008
412008
sl3: Modern pipelines for machine learning and Super Learning
JR Coyle, NS Hejazi, I Malenica, RV Phillips, O Sofrygin
R package version 1 (2), 2021
402021
Targeted learning with daily EHR data
O Sofrygin, Z Zhu, JA Schmittdiel, AS Adams, RW Grant, MJ van der Laan, ...
Statistics in medicine 38 (16), 3073-3090, 2019
372019
Mediation of neighborhood effects on adolescent substance use by the school and peer environments
KE Rudolph, O Sofrygin, NM Schmidt, R Crowder, MM Glymour, J Ahern, ...
Epidemiology 29 (4), 590-598, 2018
372018
Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria
TE Delea, O Sofrygin, JL Palmer, H Lau, VC Munk, J Sung, A Charney, ...
Journal of the American Society of Nephrology 20 (10), 2205-2213, 2009
342009
Use of machine learning to develop a risk-stratification tool for emergency department patients with acute heart failure
DR Sax, DG Mark, J Huang, O Sofrygin, JS Rana, SP Collins, AB Storrow, ...
Annals of Emergency Medicine 77 (2), 237-248, 2021
332021
Causes and consequences of child growth failure in low-and middle-income countries
A Mertens, J Benjamin-Chung, JM Colford Jr, J Coyle, MJ van der Laan, ...
MedRxiv, 2020.06. 09.20127100, 2020
322020
Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab
TE Delea, P Tappenden, O Sofrygin, D Browning, MM Amonkar, J Karnon, ...
The European Journal of Health Economics 13, 589-603, 2012
322012
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
M Vera-Llonch, E Dukes, J Rejas, O Sofrygin, M Mychaskiw, G Oster
The European Journal of Health Economics 11, 35-44, 2010
272010
The system can't perform the operation now. Try again later.
Articles 1–20